The chemical industry should not get to dictate the terms by which it is regulated.
The jockeying among presidential hopefuls in recent weeks has generated a new round of criticism of what’s called the “Wealth Primary” – the informal, but often decisive vetting of candidates by mega-donors.
Two weeks ago, an expected milestone of sorts in the debate over chemical policy seemed to turn abruptly into a headstone. Senators Vitter and Udall were expected to release a revised version of their Chemical Safety Improvement Act (CSIA) that responded to many of the concerns of health and environment leaders from across the country.
Who does your Senator turn to for children’s health advice?
Cruising the halls of Congress can be fun when you’re side by side with leading physicians and scientists. I think I started to get a little bit smarter last week when I spent time on the hill with our coalition partner experts… Osmosis works that way right? We met with sixteen U.S. Senate offices in […]
With the elections behind us, it’s time to take stock of their meaning for our chemical reform effort. In short: things are looking bright. There will certainly be a debate in the full U.S. Senate and in statehouses around the country next year. We are in a good position to win that debate.